Covid-19 Vaccine Nationalism and International Human Rights Law
Main Article Content
Abstract
The rollout of COVID-19 vaccines was referred to as the “parallel pandemic of human rights” of some sort, running neck to neck with the pandemic itself. The production, distribution, and profiteering that followed the announcement of vaccines were so unequal, between the rich countries of the global north and their poor counterparts in the global south, that the exercise was satirically termed ‘vaccine nationalism’ or ‘vaccine apartheid’. Against the backdrop of the COVID-19 pandemic, this article examines the extent to which existing International Human Rights Law (IHRL) provides for a framework of equity in vaccine distribution across the globe, particularly in the context of pushing back ‘vaccine nationalism’. Given that the questions relating to access to vaccines sit at the intersection of intellectual property (IP) protection and human rights, the article examines the delicate balance between IP protection and the broader rights of users/society to vaccine access. The article then proceeds to discuss how far human rights jurisprudence can go in engendering access to vaccines for all.
Article Details

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
References
Smith Rhona, International human rights law (USA: Oxford University Press, 2022).
See WHO Newsletter of 20 July 2020 available at https://www.who.int/news-room/photo-story/photo-story-detail/No-one-is-safe-from-COVID19-until-everyone-is-safe (accessed December 9, 2021).
Sonya Sceats, ‘COVID-19 Brings Human Rights into Focus’, Chatham House, April 3, 2020, https://www.chathamhouse.org/2020/04/covid-19-brings-human-rights-focus (accessed March 30, 2021).
Ibid.
CESCR, ‘CESCR General Comment No. 14: The Right to Highest Attainable Standard of Health (Art.12)’, adopted at the Twenty-Second Session of the Committee on Economic Social and Cultural Rights August 11, 2000, Contained in Document E/C.12/2000/4, https://www.refworld.org/pdfid/4538838d0.pdf (accessed March 30, 2021).
Krista OEHLE, et al, ‘Access to Medicines and Human Rights’, Health and Human Rights Resources Guide: FXB Health and Human Rights Centre, Harvard University, (2017), https://core.ac.uk/reader/232506070 (accessed March 31, 2021).
Cristina Calvano, ‘UN Expert Deem Accessible COVID-19 Vaccine a Human Rights Issue’, Human Rights Pulse, February 16, 2021, https://www.humanrightspulse.com/mastercontentblog/un-experts-deem-accessible-covid-19-vaccine-a-human-rights-issue (accessed March 30, 2021).
OXFAM, ‘Rich Countries Block COVID-19 Vaccines Waiver at World Trade Organisation: Oxfam Reaction’, OXFAM International, March 11, 2021, https://www.oxfam.org/en/press-releases/rich-countries-block-covid-19-vaccines-waiver-world-trade-organization-oxfam accessed 30/03/2021; Andrew Green, ‘At WTO, a Battle for Access to COVID-19 Vaccines’, Devex, December 15, 2020, https://www.devex.com/news/at-wto-a-battle-for-access-to-covid-19-vaccines-98787 (accessed March 30, 2021).
See, e.g., Elijah Paintsil, ‘COVID-19 Threatens Health Systems in Sub-Sahara Africa: The Eye of the Crocodile’, The Journal of Clinical Investigation 130, no. 6 (2020): 2741 – 2744.
Colin Binns, Wah Yun Low and Lee Mi Kyung, ‘The COVID-19 Pandemic: Public Health and Epidemiology,’ Asia Pacific Journal of Public Health 32, no. 4 (2020): 140 – 144.
See Elijah Paintsil, COVID-19 Threatens Health Systems in Sub-Sahara Africa, supra note 7, at 2741.
Ibid.
Shabir Ahmad Lone and Aijaz Ahmad, ‘COVID-19 Pandemic: An African Perspective’, Emerging Microbes & Infections 9, no. 1 (2020): 1300 – 1308.
Atieme J. Ogbolosingha and Ayesha Singh, ‘COVID-19 Pandemic: Review of Impediments to Public Health Measures in Sub-Sahara Africa’, American Journal of Preventive Medicine and Public Health 6, no. 3 (2020): 68 – 75; Malcolm R. Sim, ‘The COVID-19 Pandemic: Major Risks to Healthcare and Other Workers on the Frontline’, Occupational & Environmental Medicine 77, no. 5 (2020): 281 – 282; WHO, ‘Novel Coronavirus – China’, World Health Organisation (WHO), January 12, 2020 https://www.who.int/csr/don/12-january-2020-novel-coronavirus-china/en/ (accessed March 24, 2021); Jiumeng Sun, et al, ‘COVID-19: Epidemiology, Evolution and Cross Disciplinary Perspectives’, Trends in Molecular Medicine 26, no. 5 (2020): 483- 495; Augustine A. Onyeaghala and Isiramen Olajide, ‘Managing COVID-19 Outbreak in Nigeria: Matters Arising’, Clinical Medicine and Laboratory Medicine 58, no. 10 (2020):1645 – 1650; Oluwatosin Wuraola Akande and Tanimola Makanjuola Akande, ‘COVID-19 Pandemic: A Global Health Burden’, The Nigerian Postgraduate Medical Journal 27, no. 3 (2020): 147 – 155.
Ibid.
See WHO, ‘Novel Coronavirus – China’, World Health Organisation (WHO), January 12, 2020, https://www.who.int/csr/don/12-january-2020-novel-coronavirus-china/en/ (accessed March 24, 2021).
Elijah Paintsil, ‘COVID-19 Threatens Health Systems in Sub-Sahara Africa: The Eye of the Crocodile’, The Journal of Clinical Investigation 130, no. 6 (2020): 2741 – 2744.
Ibid.
WHO, ‘Novel Coronavirus (2019-nCoV)’, World Health Organisation (WHO) Situation Report -10, (January 30, 2020), 1.
Peter Byass, ‘Eco-epidemiological Assessment of the COVID-19 Epidemic in China, January – February 2020’, Global Health Action 13, no. 1 (2020): 1 – 8.
Kathleen Liddell, et al, ‘Who Gets the Ventilator? Important Legal Rights in a Pandemic’, Journal of Medical Ethics, 46 (2020): 421-426.
Julius A. Aminu, ‘The Implications of Misconceptions about Coronavirus Disease (COVID-19) Pandemic in Relation to its Daily Increases from Nigerian Perspective’, Journal of Infectious Disease and Epidemiology 6, no. 5 (2020): 1 – 13.
Julius A. Aminu, ‘The Implications of Misconceptions about Coronavirus Disease (COVID-19) Pandemic in Relation to its Daily Increases from Nigerian Perspective’, Journal of Infectious Disease and Epidemiology 6, no. 5 (2020): 1 – 13.
Janice H. Tanne, et al, ‘COVID-19: How Doctors and Health care Systems are tackling Coronavirus Worldwide’, British Medical Journal 18, no. 368 (2020), https://www.bmj.com/content/368/bmj.m1090?utm_source=TrendMD&utm_medium=cpc&utm_campaign=The_BMJ%253A_Research_TrendMD_0 (accessed March 24, 2021).
Ibid.
Kathleen Liddell, et al, ‘Who Gets the Ventilator? Important Legal Rights in a Pandemic’, Journal of Medical Ethics, 46 (2020): 421-426 .
Shabir Ahmad Lone and Aijaz Ahmad, ‘COVID-19 Pandemic: An African Perspective’, Emerging Microbes & Infections 9, no. 1 (2020): 1300 – 1308.
Siddharth Dixit, Yewande K. Ogundeji and Obinna Onwujekwe, ‘How Well has Nigeria responded to COVID-19?’, Brookings, July 2, 2020, https://www.brookings.edu/blog/future-development/2020/07/02/how-well-has-nigeria-responded-to-covid-19/ (accessed March 24, 2021).
Andrea Remuzzi and Giuseppe Remuzzi, ‘COVID-19 and Italy: What Next?’, Lancet 11, no. 395 (2020): 1225-1228.
Dixit, Ogundeji and Onwujekwe, supra (note 21); Sun, et al, supra (note 12).
Claire Felter, ‘How Dangerous Are New COVID-19 Strains?’, Council on Foreign Relations (CFR), January 7, 2021, https://www.cfr.org/in-brief/how-dangerous-are-new-covid-19-strains (accessed March 24, 2021).
Binns, Low and Kyung, supra (note, 8) at 4.
Ibid.
WHO, Update on Omicron Virus available at https://www.who.int/news/item/28-11-2021-update-on-omicron (accessed December 9, 2021.
Ibid.
Pfizer, ‘Pfizer and BioNTech Announce Vaccine Candidate Against COVID-19 Achieved Success in First Interim Analysis from Phase 3 Study’, PFIZER, November 9, 2020, https://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-announce-vaccine-candidate-against (accessed March 24, 2021).
Pfizer, ‘Pfizer and BioNTech Announce Vaccine Candidate Against COVID-19 Achieved Success in First Interim Analysis from Phase 3 Study’, PFIZER, November 9, 2020, https://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-announce-vaccine-candidate-against (accessed March 24, 2021).
Morgan Winsor, ‘Pfizer, BioNTech Submit Emergency Authorisation Request to FDA Friday for COVID-19 Vaccine’, ABC News, November 20, 2020, https://abcnews.go.com/Health/pfizer-biontech-submit-emergency-authorization-request-fda-friday/story?id=74313267 (accessed March 24, 2021).
Sony Salzman, ‘Moderna Announces Initial Phase 3 Data Showing its COVID-19 Vaccine is up to 94.5% Effective’, ABC News, November 16, 2020, https://abcnews.go.com/Health/moderna-announces-initial-phase-data-showing-covid-19/story?id=74227175 (accessed March 24, 2021).
Sony Salzman, ‘Moderna Announces Initial Phase 3 Data Showing its COVID-19 Vaccine is up to 94.5% Effective’, ABC News, November 16, 2020, https://abcnews.go.com/Health/moderna-announces-initial-phase-data-showing-covid-19/story?id=74227175 (accessed March 24, 2021).
Kate Duffy, ‘Pfizer and Moderna Have both asked the EU to Approve their COVID-19 Vaccines – But First Shots might not come until Next Year’, Business Insider Africa, December 1, 2020, https://africa.businessinsider.com/health/pfizer-and-moderna-have-both-asked-the-eu-to-approve-their-covid-19-vaccines-but/v8fc47b (accessed March 24, 2021).
Emma Reynolds, Stephanie Halasz, Frederik Pleitgen and Lindsay Isaac, ‘UK Becomes First Country to Authorise Pfizer/BioNTech COVID-19 Vaccine, First Shots roll out Next Week’, CNN, December 3, 2020, https://edition.cnn.com/2020/12/02/uk/pfizer-coronavirus-vaccine-uk-intl-hnk/index.html (accessed March 24, 2021); Bojan Pancevski, Jenny Strasburg and Jared S. Hopkins, ‘UK Authorises Pfizer, BioNTech COVID-19 Vaccine for Emergency Use’, The Wall Street Journal, December 2, 2020, https://www.wsj.com/articles/pfizer-and-biontechs-covid-19-vaccine-wins-u-k-authorization-11606893360 (accessed March 24, 2021).
Jessica Elgot and Ian Sample, ‘UK Scramble to Buy 5m Doses of COVID Breakthrough Vaccine’, The Guardian, November 16, 2020, https://www.theguardian.com/world/2020/nov/16/uk-in-advanced-discussions-to-buy-moderna-covid-vaccine (accessed March 24, 2021).
Jessica Elgot and Ian Sample, ‘UK Scramble to Buy 5m Doses of COVID Breakthrough Vaccine’, The Guardian, November 16, 2020, https://www.theguardian.com/world/2020/nov/16/uk-in-advanced-discussions-to-buy-moderna-covid-vaccine (accessed March 24, 2021); Georgina Hayes, ‘UK Orders 5m Doses of Moderna Coronavirus Vaccine’, The Telegraph, November 16, 2020, https://www.telegraph.co.uk/global-health/science-and-disease/coronavirus-news-update-covid-19-lockdown-end-vaccine/ (accessed March 24, 2021.
Anne Gulland, Annelies Gartner and Lizzie Roberts, ‘From Transmission to Efficacy, How the AstraZeneca, Pfizer and Other Covid Vaccines Compare’, The Telegraph, March 24, 2021, https://www.telegraph.co.uk/global-health/science-and-disease/covid-vaccine-pfizer-vs-oxford-astrazeneca-difference-compared/ (accessed March 24, 2021).
‘COVID-19 Vaccine Tracker’, https://covid19.trackvaccines.org/ (accessed March 24, 2021).
Ibid.
Anne Gulland, Annelies Gartner and Lizzie Roberts, ‘From Transmission to Efficacy, How the AstraZeneca, Pfizer and Other Covid Vaccines Compare’, The Telegraph, March 24, 2021, https://www.telegraph.co.uk/global-health/science-and-disease/covid-vaccine-pfizer-vs-oxford-astrazeneca-difference-compared/ (accessed March 24, 2021).
Jerome Amir Singh and Ross EG Upshur, ‘The granting of emergency use designation to COVID-19 candidate vaccines: implications for COVID-19 vaccine trials’, The Lancet Infectious Diseases12, no. 4 (2021): e103-e109.
Ann Danaiya Usher,‘COVID-19 vaccines for all?’, The Lancet 395, no. 10240 (2020): 822-1823.
Lynsey Chutel and Marc Santora, ‘A Virus Variant Spreads, No One is Safe Until Everyone Safe’, New York Times, January 31, 2021, https://www.nytimes.com/2021/01/31/world/africa/coronavirus-south-africa-variant.html (accessed March 24, 2021).
WHO African Regional Office available at 'Absolutely Unacceptable' COVID-19 Vaccination Rates in Developing Countries, The Development Podcast
https://www.afro.who.int/news/less-10-african-countries-hit-key-covid-19-vaccination-goal (accessed December 8, 2021).
The World Bank, https://www.worldbank.org/en/news/podcast/2021/07/30/-absolutely-unacceptable-vaccination-rates-in-developing-countries-the-development-podcast (accessed December 8, 2021).
ALJAZEERA Opinion, Omicron: Vaccine nationalism will only perpetuate the pandemic https://www.aljazeera.com/opinions/2021/11/28/omicron-vaccine-nationalism-will-only-perpetuate-the-pandemic (accessed December 8, 2021).
United Nations, ‘Vaccine Nationalism, Hoarding Putting Us All at Risk, Secretary‑General Tells World Health Summit, Warning COVID‑19 Will Not Be Last Global Pandemic’, https://www.un.org/press/en/2021/sgsm20986.doc.htm (accessed December 9, 2021).
Rebecca Weintraub, Prashant Yadav and Seth Berkley, ‘A Covid-19 Vaccine will Need Equitable, Global Distribution’, Harvard Business Review, April 2, 2020, https://hbr.org/2020/04/a-covid-19-vaccine-will-need-equitable-global-distribution (accessed March 30, 2021).
Lars Kohn, et al, ‘Vaccination as a Social Contract’, PNAS 117, no. 26 (2020): 14890-14899.
Rebecca Weintraub, Prashant Yadav and Seth Berkley, ‘A Covid-19 Vaccine will Need Equitable, Global Distribution’, Harvard Business Review, April 2, 2020, https://hbr.org/2020/04/a-covid-19-vaccine-will-need-equitable-global-distribution (accessed March 30, 2021).
Allyson Berri, ‘The Global Cost of Vaccine Nationalism’, Diplomatic Courier, March 24, 2021, https://www.diplomaticourier.com/posts/the-global-cost-of-vaccine-nationalism (accessed March 31, 2021).
Ana Santos Rutschman, ‘Is There a Cure for Vaccine Nationalism?’, Current History 120, no. 822 (2021), https://online.ucpress.edu/currenthistory/article/120/822/9/114551/Is-There-a-Cure-for-Vaccine-Nationalism (accessed March 31, 2021).
Ana Santos Rutschman, ‘Is There a Cure for Vaccine Nationalism?’, Current History 120, no. 822 (2021), https://online.ucpress.edu/currenthistory/article/120/822/9/114551/Is-There-a-Cure-for-Vaccine-Nationalism (accessed March 31, 2021).
Tracey Anne Duncan, ‘The Deadly Ramifications of Vaccine Nationalism’, MIC, January 15, 2021, https://www.mic.com/p/the-deadly-ramifications-of-vaccine-nationalism-57756166 (accessed March 31, 2021).
Salma Daoudi, ‘Vaccine Nationalism in the Context of COVID-19: An Obstacle to the Containment of the Pandemic’, Policy Centre for the New South, September, 2020: 1 - 10, https://media.africaportal.org/documents/PB_-_20-71_Salma_Daoudi_EN.pdf (accessed March 31, 2021).
Peter S. Goodman, et al, ‘A New Front for Nationalism: The Global Battle Against a Virus’, The New York Times, April 22, 2020, https://www.nytimes.com/2020/04/10/business/coronavirus-vaccine-nationalism.html (accessed March 31, 2021).
Brook Baker, ‘US, China and EU First Nationalism and COVID-19 Technology Hoarding Push the Rest of the World to the End of the Line’, Health Gap: Global Health Project, June 5, 2020, https://healthgap.org/u-s-china-and-eu-first-nationalism-and-covid-19-technology-hoarding-push-the-rest-of-the-world-to-the-end-of-the-line/ (accessed March 30, 2021).
Harry Kretchmer, ‘Vaccine Nationalism – And How it could Affect Us All’, World Economic Forum, January 6, 2021, https://www.weforum.org/agenda/2021/01/what-is-vaccine-nationalism-coronavirus-its-affects-covid-19-pandemic/ (accessed March 31, 2021).
Fiona Reynolds, ‘Vaccine Nationalism: Why Responsible Investors Must Change the Course of Action’, Principles for Responsible Investment (PRI), March 4, 2021, https://www.unpri.org/vaccine-nationalism-why-responsible-investors-must-change-the-course-of-action/7312.article (accessed March 30, 2021).
Salma Daoudi, ‘Vaccine Nationalism in the Context of COVID-19: An Obstacle to the Containment of the Pandemic’, Policy Centre for the New South, September 2020, https://media.africaportal.org/documents/PB_-_20-71_Salma_Daoudi_EN.pdf (accessed March 31, 2021).
Tedros Adhanom Ghebreyesus, ‘Vaccine Nationalism Harms Everyone and Protects No One’, Foreign Policy (FP), February 2, 2021, https://foreignpolicy.com/2021/02/02/vaccine-nationalism-harms-everyone-and-protects-no-one/ (accessed March 31, 2021).
Nanjala Nyabola, ‘Vaccine Nationalism is Patently Unjust’, The Nation, March 22, 2021, https://www.thenation.com/article/world/coronavirus-vaccine-justice/ (accessed March 31, 2021).
Raisa Patel and Rosemary Barton, ‘Vaccine Nationalism an Issue of Enlightened Self-Interest UN Secretary General Warns’, CBC, March 28, 2021, https://www.cbc.ca/news/politics/vaccine-nationalism-antonio-guterres-1.5967306 (accessed March 31, 2021).
Raisa Patel and Rosemary Barton, ‘Vaccine Nationalism an Issue of Enlightened Self-Interest UN Secretary General Warns’, CBC, March 28, 2021, https://www.cbc.ca/news/politics/vaccine-nationalism-antonio-guterres-1.5967306 (accessed March 31, 2021).
Olga Krasnyak, ‘From Vaccine Nationalism to Vaccine Diplomacy: Eradicating COVID-19 Demands Global Leadership’, Asia & The Pacific Policy Society, https://www.policyforum.net/from-vaccine-nationalism-to-vaccine-diplomacy/ (accessed March 31, 2021).
Nanjala Nyabola, ‘Vaccine Nationalism is Patently Unjust’, The Nation, March 22, 2021, https://www.thenation.com/article/world/coronavirus-vaccine-justice/ (accessed March 31, 2021).
Evaborhene Aghogho Nelson, ‘Vaccine Nationalism and Africa’, Think Global Health, September 17, 2020, https://www.thinkglobalhealth.org/article/vaccine-nationalism-and-africa (accessed March 31, 2021).
Evaborhene Aghogho Nelson, ‘Vaccine Nationalism and Africa’, Think Global Health, September 17, 2020, https://www.thinkglobalhealth.org/article/vaccine-nationalism-and-africa (accessed March 31, 2021).
Harris Meyer, ‘After a COVID-19 Vaccine: Collaboration or Competition?’, Health Affairs 39, no. 11 (2020), https://www.healthaffairs.org/doi/full/10.1377/hlthaff.2020.01732 (accessed March 31, 2021).
Roberts Yates, ‘Time to Clampdown on Dangers of Vaccine Nationalism’, Chatham House, February 11, 2021, https://www.chathamhouse.org/2021/02/time-clamp-down-dangers-vaccine-nationalism (accessed March 31, 2021).
Diane Desierto, ‘Equitable COVID Vaccine Distribution and Access: Enforcing International Obligations under Economic, Social and Cultural Rights and the Right to Development’, EJIL: Talk – Blog of the European Journal of International Law, February 2, 2021, https://www.ejiltalk.org/equitable-covid-vaccine-distribution-and-access-enforcing-international-legal-obligations-under-economic-social-and-cultural-rights-and-the-right-to-development/ (accessed March 30, 2021).
Jeremy Booth, ‘Vaccine Nationalism Poses threat to Global Health’, Dental Tribune, March 25, 2021, https://coronavirus.dental-tribune.com/news/vaccine-nationalism-poses-threat-to-global-health/ (accessed March 31, 2021).
Jeremy Booth, ‘Vaccine Nationalism Poses threat to Global Health’, Dental Tribune, March 25, 2021, https://coronavirus.dental-tribune.com/news/vaccine-nationalism-poses-threat-to-global-health/ (accessed March 31, 2021).
Thomas J. Bollyky and Chad P. Bown, ‘The Tragedy of Vaccine Nationalism: Only Cooperation Can End the Pandemic’, Foreign Affairs, September/October 2020, https://www.foreignaffairs.com/articles/united-states/2020-07-27/vaccine-nationalism-pandemic (accessed March 31, 2021).
Harry Kretchmer, ‘Vaccine Nationalism – And How it could Affect Us All’, World Economic Forum, January 6, 2021, https://www.weforum.org/agenda/2021/01/what-is-vaccine-nationalism-coronavirus-its-affects-covid-19-pandemic/ (accessed March 31, 2021).
Roberts Yates, ‘Time to Clampdown on Dangers of Vaccine Nationalism’, Chatham House, February 11, 2021, https://www.chathamhouse.org/2021/02/time-clamp-down-dangers-vaccine-nationalism (accessed March 31, 2021).
James Paton and Bloomberg, ‘How Vaccine Nationalism Could Extend the Pandemic’, Fortune, January 31, 2021, https://fortune.com/2021/01/31/covid-vaccine-nationalism-coronavirus-pandemic-length-when-will-it-end/ (accessed March 31, 2021).
Helen Lock, ‘Vaccine Nationalism: Everything you Need to Know’, Global Citizen, February 11, 2021, https://www.globalcitizen.org/en/content/what-is-vaccine-nationalism/ (accessed March 31, 2021).
ICCCAD, ‘Vaccine Nationalism, Global Public Good and the Poort’, International Centre for Climate Change and Development (ICCCAD), February 19, 2021, http://www.icccad.net/daily-star-articles/vaccine-nationalism-global-public-good-and-the-poor/ (accessed March 31, 2021).
Allyson Berri, ‘The Global Cost of Vaccine Nationalism’, Diplomatic Courier, March 24, 2021, https://www.diplomaticourier.com/posts/the-global-cost-of-vaccine-nationalism (accessed March 31, 2021).
Yu, PK, ‘The Objectives and Principles of the TRIPS Agreement’, Houston Law Review, 46 (2009): 797 – 1046.
See Tolulope Anthony Adekola, ‘Regional mechanism under Doha paragraph 6 system-The largely untested alternative route for access to patented medicines’. Asian J. WTO & Int'l Health L & Pol'y 15 (2020): 61.
See article 12 of the ICESCR
Owoeye O., ‘Health and Development in Africa: How Far Can the Human Rights Jurisprudence Go?’. In: Eboe-Osuji C., Emeseh E., Akinkugbe O.D. (eds) (Nigerian Yearbook of International Law 2018/2019, 2021).
See article 5 (e) (iv).
See article. 11 (1) (f), 12 and 14 (2) (b).
See article 24.
See article 28, 43 (e) and 45 (c);
See article 25.
Krista OEHLE, et al, ‘Access to Medicines and Human Rights’, Health and Human Rights Resources Guide: FXB Health and Human Rights Centre, Harvard University, 2017, https://core.ac.uk/reader/232506070 (accessed March 31, 2021).
Nomani, M. Z. M., Alaa KK Alhalboosi, and Mohammad Rauf, ‘Legal & Intellectual Property Dimension of Health & Access to Medicines in India’. Indian journal of forensic medicine & toxicology 14, no. 1 (2020).
See Ituku Elangi Botoy, ‘From the Paris Convention to the TRIPS Agreement: A One-Hundred-and-Twelve Year Transitional Period for the Industrialized Countries’, The Journal of World Intellectual Property, (2004): 115-130.
Olu Fasan, ‘Commitment and Compliance in International Law: A Study of the Implementation of the WTO TRIPS Agreement in Nigeria and South Africa’, African Journal of International and Comparative Law 20, no. 2 (2012): 191 – 228.
Ibid.
Hall B., Helmers C., Graevenitz G. and Rosazza‐Bondibene, C. 2012. ‘A Study of Patent Thickets’, (NIESR Discussion Paper No. 401, 2012).
FM Scherer and Jayashree Watal, ‘Post-TRIPS Options for Access to Patented Medicines in Developing Nations’, Journal of International Economic Law, (2002): 913-939; Tenu Avafia and Savita Mullapudi Narasimhan, ‘The TRIPS Agreement and Access to ARVs’, prepared for the United Nations Development Programme, (2006): 1-28.
World Health Organization, ‘Addressing the global shortage of, and access to, medicines and vaccines Report by the Director- general background [Internet] World Health Assembly 2018; EB142/13:50, http://apps.who.int/gb/ebwha/pdf_files/EB142/B142_13-en.pdf%0Ahttp://apps.who. int/gb/ebwha/pdf_files/WHA70/A70_20-en.pdf.
Karsten Königer, ‘A Friendly Reminder 25 Years after TRIPs: An International Harmonisation of the Grace Period in Patent Law Remains Preferable’, Journal of Intellectual Property Law & Practice, 14 (2019): 341.
Leticia Working Watal, Jayashree; Caminero, ‘Www.Econstor.Eu’ (2018) . ERSD-2018-01.
Olasupo Owoeye, Olugbenga Olatunji and Bukola Faturoti, 'Patents and the Trans-Pacific Partnership: How TPP-Style Intellectual Property Standards May Exacerbate the Access to Medicines Problem in the East African Community’, International Trade Journal 33, no. 2 (2017): 197-218 <https://doi.org/10.1080/08853908.2017.1386143>.
Abbott (n 40).
Olufemi Soyeju, ‘The WTO–TRIPS Flexibilities on Public Health: A Critical Appraisal of the East African Community Regional Framework’, World Trade Review, 17 (2018): 145 <https://www.cambridge.org/core/product/identifier/S1474745617000143/type/journal_article>.
Peter K Yu, ‘Access to Medicines, BRICS Alliances and Collective Action’, American Journal of Law and Medicine, 34 (2008): 345.
Tolulope A. Adekola, ‘Public Health–Oriented Intellectual Property and Trade Policies in Africa and the Regional Mechanism under Trade-Related Aspects of Intellectual Property Rights Amendment’, Public Health, 173 (2019): 1-4 <https://doi.org/10.1016/j.puhe.2019.04.019>.
Dutfield G. and Suthersanen U., ‘Harmonisation or Differentiation in Intellectual Property Protection? The Lessons of History’, Occasional Paper 15, (Quaker United Nations Office: Geneva, 2004) [Online] http://www.quno.org/geneva/pdf/economic/Occassional/Harmonisation-or-Differentiation.pdf, (accessed March 10, 2011).
Wade R., ‘What strategies are viable for developing countries today? The World Trade Organization and the shrinking of ‘development space’, Review of International Political Economy 10, no. 4 (2003): 621-644.
See, generally, Siang Yong Tan and Nate Ponstein, ‘Jonas Salk (1914–1995): A Vaccine against Polio’, Singapore Medical Journal 60, no. 1 (2019): 9-10.
ibid
Tolulope A. Adekola, ‘Should COVID-19 treatment be patented? Rethinking the theoretical justification for the grant of pharmaceutical patent’, European Intellectual Property Review 42, no. 11 (2020): 695-697.
Tolulope A. Adekola 2020, 'Has the Doha Paragraph 6 system reached its limits?', Journal of Intellectual Property Law & Practice. https://doi.org/10.1093/jiplp/jpaa058
Esteban Burrone and others, ‘Patent Pooling to Increase Access to Essential Medicines’, Bulletin of the World Health Organization 97, no. 8 (2019): 575.
Ibid 116.
Tolulope Anthony Adekola, ‘Public health–oriented intellectual property and trade policies in Africa and the regional mechanism under Trade-Related Aspects of Intellectual Property Rights amendment’, public health,173 (2019): 1-4.
Ibid
ibid
See WHO: ‘Neglected Tropical Diseases’, https://www.afro.who.int/health-topics/neglected-tropical-diseases (accessed June 24, 2020).
See COVID-19: In the Shadow of Ebola, the Patent War to Come and a Forgotten Africa https://openair.africa/covid-19-in-the-shadow-of-ebola-the-patent-war-to-come-and-a-forgotten-africa/ (accessed June 24, 2020).
See WHO; Malaria report 2020 https://www.who.int/news-room/fact-sheets/detail/malaria (accessed June 24, 2020).
Lawrence O. Gostin, et al, ‘The Joint Action and Learning Initiative: Towards a Global Agreement on National and Global Responsibilities for Health’, Plos Medicine 8, no. 5 (2011), https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1001031 (accessed March 31, 2021).
Subramanian L. and Nayler J., ‘Africa’s COVID-19 Supply Chain and Logistics Readiness’, (Pamela Steele Associates Ltd. 2021), 1 -19 at 4, https://www.pamsteele.co.uk/wp-content/uploads/2021/03/20210308_Africa_Covid_Vaccine_Logistics_Final.pdf (accessed March 30, 2021).
OHCHR, ‘Human Rights and Access to COVID-19 Vaccines’, United Nations Human Rights: Office of the Hugh Commissioner, December 17, 2020, https://www.ohchr.org/Documents/Events/COVID-19_AccessVaccines_Guidance.pdf, (accessed March 30, 2021).
OHCHR, ‘Statement by UN Human Rights Experts Universal Access to Vaccines is Essential for Prevention and Containment of COVID-19 around the World’, United Nations Human Rights: Office of the High Commissioner, November 9, 2020, https://www.ohchr.org/EN/NewsEvents/Pages/DisplayNews.aspx?NewsID=26484&LangID=E (accessed March 30, 2021).
OHCHR, ‘No Exceptions with COVID-19: Everyone has a Right to Life-saving Interventions – UN Expert Says’, United Nations Human Rights: Office of the High Commissioner, https://www.ohchr.org/EN/NewsEvents/Pages/DisplayNews.aspx?NewsID=25746&LangID=E (accessed March 30, 2021).
AIGHD, ‘Fair Distribution of COVID-19 Vaccines: Who is Responsible?’, Amsterdam Institute for Global Health and Development (AIGHD), March 5, 2021, https://www.aighd.org/2021/03/05/fair-distribution-of-covid-19-vaccines-who-is-responsible/ (accessed March 30, 2021).
Oona Hathaway, Mark Stevens and Preston Lim, ‘COVID-19 and International Law Series: Human Rights Law – Right to Health’, Just Security, November 20, 2020, https://www.justsecurity.org/73447/covid-19-and-international-law-series-human-rights-law-right-to-health/ (accessed March 30, 2021).
Joseph Bae, et al, ‘Vaccines For All: Challenges and Potential Solutions for Equitable COVID-19 Vaccine Distribution’, (Position Paper for Conference at Massachusetts Institute of Technology (MIT), December 2020, https://pandemic.mit.edu/assets/files/PositionPaper.pdf (accessed March 31, 2021).
Heather Wipfli and Daniel Luo, ‘The Emperor’s Institutions: Does COVID-19 Vaccine Distribution Demonstrate the Failure of Multilateralism?’, Politics & Society, Science & Technology, The University of Auckland, New Zealand, https://www.thebigq.org/2021/03/16/the-emperors-institutions-does-covid-19-vaccine-distribution-demonstrate-the-failure-of-multilateralism/ (accessed March 31, 2021).
UN, ‘WHO Chief Warns Against COVID-19 Vaccine Nationalism, Urges Support for Fair Access’, UN News, August 18, 2020, https://news.un.org/en/story/2020/08/1070422 (accessed March 31, 2021).
Jonathan Josephs, ‘New WTO Boss Warns Against Vaccine Nationalism’, BBC News, February 16, 2021, https://www.bbc.com/news/business-56079088 (accessed March 31, 2021).
Reidar.K. Lie and Franklin.G. Miller, ‘Allocating a COVID-19 Vaccine: Balancing National and International Responsibilities’, Milbank Quarterly, December 9, 2020, https://www.milbank.org/quarterly/articles/allocating-a-covid-19-vaccine-balancing-national-and-international-responsibilities/ (accessed March 31, 2021).
Margaret Labban and Milena Izmirlieva, ‘Vaccine Nationalism Versus Cooperation: Global Challenges During the COVID-19 Pandemic’, HIS Markit, July 7, 2020, https://ihsmarkit.com/research-analysis/vaccine-nationalism-versus-cooperation-global-challenges-covid.html (accessed March 31, 2021).
Rebecca Weintraub, Prashant Yadav, and Seth Berkley, ‘A Covid-19 Vaccine will Need Equitable, Global Distribution’, Harvard Business Review, April 2, 2020, https://hbr.org/2020/04/a-covid-19-vaccine-will-need-equitable-global-distribution (accessed March 30, 2021).